Vanguard Capital Management’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
Vanguard Capital Management's LPCN Position: Q3 2026 in Review
Vanguard Capital Management held its Lipocine (LPCN) position steady in Q3 2026 at 230,823 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #3679.
Vanguard Capital Management first reported a position in LPCN in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.6M in Q1 2026. 24 funds tracked by Wall St. Rank hold LPCN as of Q3 2026.
- Vanguard Capital Management held 230,823 shares of Lipocine worth $508K as of Q3 2026.
- Vanguard Capital Management left its Lipocine share count unchanged in Q3 2026.
- Lipocine made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3679 holding.
- Vanguard Capital Management first reported a position in Lipocine in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Lipocine position peaked at $1.6M in Q1 2026.
- 24 funds tracked by Wall St. Rank held Lipocine as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.